vrc-hivmab060-00-ab
mAbexperimental
Clinical trial activity
17 trials · 14 clinical orgs · 0 marketing orgs
Phase 1
13
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Aug 22, 2013 (NCT01950325)
Timeline
Indications
Mechanism of action
- T-cell surface antigen CD4INHIBITOR
CD4 inhibitor
- Human immunodeficiency virusImmunity, passive
Human immunodeficiency virus immunity, passive
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
- Payload
- 89-Zirconium
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4650525 ↗
Also known as
- vrc01
- vrc-hivmab01060-00-ab
- vrc-hivmab060-00-ab
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03831945 | Phase 1 | Apr 4, 2019 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT03729752 | Phase 1 | Nov 1, 2018 | AmFAR, University of California, San Francisco |
| NCT03208231 | Phase 1/Phase 2 (Phase 2) | May 8, 2018 | National Institute of Allergy and Infectious Diseases (NIAID), New York University, University of Colorado |
| NCT02797171 | Phase 1 | Mar 1, 2017 | Desmond Tutu HIV Centre, National Institute of Allergy and Infectious Diseases (NIAID), University of Washington |
| NCT03036709 | Phase 2 | Aug 1, 2016 | South East Asia Research Collaboration with Hawaii |
| NCT02664415 | Phase 2 | Aug 1, 2016 | National Institute of Allergy and Infectious Diseases (NIAID), United States Army |
| NCT02568215 | Phase 2 | May 1, 2016 | National Institute of Allergy and Infectious Diseases (NIAID), University of North Carolina at Chapel Hill, University of Washington |
| NCT02591420 | Phase 1 | Apr 1, 2016 | National Institute of Allergy and Infectious Diseases (NIAID), United States Army |
| NCT02716675 | Phase 2 | Mar 1, 2016 | National Institute of Allergy and Infectious Diseases (NIAID), University of North Carolina at Chapel Hill, University of Washington |
| NCT02599896 | Phase 1 | Oct 30, 2015 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02463227 | Phase 1 | Aug 1, 2015 | National Institute of Allergy and Infectious Diseases (NIAID), University of Pennsylvania |
| NCT02471326 | Phase 1 | Jun 1, 2015 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02411539 | Phase 1 | May 1, 2015 | National Institute of Allergy and Infectious Diseases (NIAID), Pitt CRS |
| NCT02256631 | Phase 1 | Apr 1, 2015 | Duke University, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02165267 | Phase 1 | Aug 1, 2014 | National Institute of Allergy and Infectious Diseases (NIAID), The Fenway Institute |
| NCT01993706 | Phase 1 | Nov 19, 2013 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01950325 | Phase 1 | Aug 22, 2013 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 17 of 17 trials
Page 1 / 1
Organizations
Research & Development (14)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 15 | 15 | 2 | 2013 |
| University of Washington | Academic/Hospital | 3 | 0 | 2 | 2016 |
| United States Army | Government | 2 | 0 | 2 | 2016 |
| University of North Carolina at Chapel Hill | Academic/Hospital | 2 | 0 | 1 | 2016 |
| AmFAR | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Desmond Tutu HIV Centre | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Duke University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| New York University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Pitt CRS | Academic/Hospital | 1 | 0 | 1 | 2015 |
| South East Asia Research Collaboration with Hawaii | Academic/Hospital | 1 | 1 | 1 | 2016 |
| The Fenway Institute | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Colorado | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2015 |
14 organizations
Page 1 / 1